Tylesa Webb, in Spartanburg, SC - Licensed Vocational Nurse

Tylesa Webb, is a Licensed Vocational Nurse based in Spartanburg, South Carolina. Tylesa Webb is licensed to practice in South Carolina (license number 51051) and her current practice location is 1035 N Church St, Spartanburg, South Carolina. She can be reached at her office (for appointments etc.) via phone at (864) 760-8501.

NPI number for Tylesa Webb is 1154083806 and her current mailing address is 1035 N Church St, Spartanburg, South Carolina. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1154083806.

Contact Information

	Tylesa Webb,
	1035 N Church St, Spartanburg, SC 29303-2714
	(864) 760-8501
	Not Available

Provider's Profile

Full Name	Tylesa Webb
Gender	Female
Speciality	Licensed Vocational Nurse
Location	1035 N Church St, Spartanburg, South Carolina
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1154083806
Provider Enumeration Date: 10/11/2021
Last Update Date: 10/11/2021

Medical Identifiers

Medical identifiers for Tylesa Webb such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1154083806	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
164X00000X	Licensed Vocational Nurse	51051 (South Carolina)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Tylesa Webb is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Tylesa Webb, 1035 N Church St, Spartanburg, SC 29303-2714 Ph: () -	Tylesa Webb, 1035 N Church St, Spartanburg, SC 29303-2714 Ph: (864) 760-8501

News Archive

Response Biomedical continues global market expansion, signs Guangzhou Wondfo Biotech in China

Response Biomedical Corporation announced that the Company has signed a second partner, Guangzhou Wondfo Biotech Co., Ltd. (Wondfo) in China to sell the Company's diagnostic products, expanding its strategic presence in this important global market.

Varenicline may reduce smoking rates before people try to quit

Smokers planning to kick the habit may have more success if they begin using a cessation medication several weeks before they actually try to quit.

IntegraGen, Lab21 collaborate to develop new microRNA assay for colorectal cancer

Lab21 Limited, the global specialist in personalised medicine and clinical diagnostics, has entered into an agreement with IntegraGen, a leading player in the development and marketing of molecular diagnostic testing in autism and oncology, to develop a microRNA assay for colorectal cancer designed to further improve patient outcomes.

FDA files consent decree against STERIS

The U.S. Food and Drug Administration today announced that a consent decree has been filed against the device manufacturer, STERIS Corp. of Mentor, Ohio. The decree stops the company from distributing unapproved and misbranded devices used to sterilize heat-sensitive instruments and medical devices. It prohibits the distribution of the STERIS System 1 Processor, or SS1, a tabletop liquid chemical system marketed to disinfect certain devices, such as endoscopes, that cannot withstand steam sterilization.

Tylesa Webb, - Licensed Vocational Nurse in Spartanburg, SC